Worldwide: Digital Health Law Update Vol. 1 Issue 5

Industry Insights

Jones Day partners Todd Kelly and Elizabeth Myers and associate Eric Jackson recently coauthored an article titled "While Rules Evolve Telemedicine is Alive and Well in Texas," published in Texas Lawyer. The article explores various telemedicine models that are being used in America's second most populous state, despite the uncertainty and litigation disputes regarding recent amendments to the Texas Medical Board's rules on telemedicine and prescribing that threaten some direct-to-consumer delivery models. The article concludes that "little has changed consultations among licensed providers or referrals by physicians who have already evaluated the patient."

Reprinted with permission from the September 2015 edition of Texas Lawyer. © 2015 ALM Media Properties, LLC. All rights reserved. Further duplication without permission is prohibited.

Federal Features

ONC—The Office of National Coordinator for Health Information Technology ("ONC") recently released a white paper, titled Designing the Consumer-Centered Telehealth & eVisit Experience: Considerations for the Future of Consumer Healthcare, which ONC had commissioned as a summary of its April 2015 design workshop on the topic.

According to the paper, the workshop identified the following nine guidelines for consumer-centered telehealth:

  • There cannot be friction for the user.
  • Team-based care must include smart triggers.
  • Real world and online world must converge.
  • We must be sensitive to data overload.
  • Consumers are the hubs of their own health care data.
  • Converge data for interactions to be safe and meaningful.
  • Expand role for care team based on new data triggers.
  • Integrate technology and human interaction in the physical world.
  • Increase focus on patient data security.


Although the paper explains that it should not be interpreted as a policy statement of ONC, it does provide an overview of the state regulatory landscape, other challenges faced by telehealth providers, and general principles for what it describes as four levels of the integration-to-fracturing of care: (i) integrated care (primary care provider ("PCP"), patient, and family members); (ii)telehealth-enabled care (use of telehealth by same PCP); (iii) extended integration (telehealth-enabled encounter with networked providers); and (iv) outside care (telehealth-enabled encounters with "one-off" clinicians, i.e., no preexisting relationship). The white paper indicates that ONC expects to continue discussing these issues and has a stated goal of expanding the adoption and use of telehealth and mobile health.

FTC—On September 17, 2015, the Consumer Protection Bureau of the Federal Trade Commission ("FTC") released details of a recent enforcement action against the marketers of a mobile application that provides visual exercises focused on reading and other activities. Under the terms of a proposed settlement, the company has agreed to disgorge $150,000 and to stop making certain claims about the app. The FTC had alleged that the company did not have scientific evidence to support its claims that the app could improve users' vision. This action serves as a reminder of the importance for careful consumer disclosures and registration terms, especially for mHealth apps.

Telehealth Legislation—Members of Congress and outside organizations continue to discuss the Telemedicine for Medicare (TELE-MED) Act of 2015, which has been introduced in both the House of Representatives and Senate. The bill would enable physicians licensed in one state to provide care remotely to Medicare patients located in other states without obtaining a license in the patient's state. Although limited to Medicare services, the bill has a similar purpose as other initiatives aimed at streamlining professional medical standards, such as the Interstate Medical Licensure Compact, which has been adopted by 11 states.

State Summaries

Alabama—On August 19, 2015, the Alabama Board of Medical Examiners announced it had repealed and immediately suspended enforcement of its telehealth rules, explaining the decision was based on its concerns regarding potential antitrust issues following the recent U.S. Supreme Court decision in North Carolina State Board of Dental Examiners v. FTC. The repealed rules included an "appropriate physical examination" requirement that limited the use of certain telehealth delivery models in the state. The Board is not expected to issue replacement rules until the state legislature approves new telehealth legislation, possibly as early as spring 2016.

Colorado—On August 20, 2015, the Colorado Medical Board issued new guidelines on the appropriate use of telehealth in the context of "direct to consumer" business models. The guidelines closely track the Model Policy of the Federation of State Medical Boards by providing that a provider–patient relationship can be established via telehealth and that the same standard of care applies to both telehealth and in-person delivery models. Other notable features include: (i) the definition of "telehealth" covers both synchronous interactions and store-and-forward transfers; (ii) the use of telehealth requires informed consent with appropriate disclosures on the modality; (iii) a formal written protocol must be developed for handling emergency services; and (iv) recommendations of medical marijuana may not be made via telehealth technologies.

Idaho—The Idaho Board of Medicine recently adopted " Guidlinesfor Appropriate Regulation of Telemedicine." The guidelines mark a significant reform for a state that has been the source of relatively high-profile enforcement actions against telehealth providers. Specifically, the new policy recognizes that a physician–patient relationship may be established remotely but advises physicians not to render medical advice or care using telemedicine without verifying the location of the patient, disclosing the provider's identity and credentials, and obtaining any special informed consents regarding the use of telemedicine technologies, among other requirements. The Board is in the process of codifying these policies into regulations and held a public hearing on the matter on September 15, 2015.

North Carolina—Pursuant to a new rule effective August 1, 2015, North Carolina pharmacists are permitted to use professional judgment in refusing to fill a prescription in cases where the prescription order's accuracy, validity, or authenticity or the patient's safety is at issue. Additionally, the rule provides that a prescription order is valid "only if it is a lawful order for a drug, device, or medical equipment issued by a health care provider for a legitimate medical purpose, in the context of a patient–prescriber relationship, and in the course of legitimate professional practice." Previously, state law had imposed an obligation on pharmacists to decline prescriptions when it was believed the prescriber had not conducted "a physical [in-person] exam" of the patient. This change helps bring the pharmacy regulations in line with current policies of the state Medical Board as it relates to telemedicine.

South Carolina—At its August 3, 2015 meeting, the S.C. Board of Medical Examiners approved a telemedicine provider guidance document and updated its advice on establishing a physician–patient relationship as a prerequisite to prescribing drugs. The guidance document clarifies that telemedicine is held to the same standard of care as in-person services. With respect to establishing a physician–patient relationship, while the Board's updated guidance indicates that such a relationship can be established solely through telemedicine, the guidance appears to require the use of patient-site ancillary providers where there is no preexisting physician–patient relationship (with limited exceptions such as writing admission orders for a newly hospitalized patient, prescribing for a patient of another licensee for whom the prescriber is taking call, and others).

Virginia—Virginia recently amended its rules regarding telemedicine prescribing. As of July 1, 2015, a prescriber may establish a practitioner–patient relationship through "two-way, real-time" communication or store-and-forward technology if the licensed prescriber has a medical history available for review, makes the diagnosis at the time of prescribing, and conforms to standards of care for in-person treatment, among other requirements.

Wisconsin—In a notice dated September 21, 2015, the Wisconsin Medical Examining Board announced it has begun the process for proposing new telemedicine regulations. The current administrative code is silent with regard to telemedicine, but the proposed rule would define the practice of telemedicine, explain how a valid physician–patient relationship can be established in a telemedicine setting, and specify licensure and technology requirements for the use of telemedicine. The notice cites federal bill H.R. 691 (Telehealth Modernization Act of 2015) as a model for the issues that will be addressed by the Wisconsin proposed rule.

Reimbursement Review

Delaware—In September 2015, the Delaware Division of Medicaid and Medical Assistance ("DMMA") adopted an amendment recognizing the Medicaid beneficiary's home as an originating site for reimbursement of interactive, real-time audio-video telemedicine. In response to public comments, the DMMA also revised the final rule to include nonresidential day programs and alternate locations as originating sites.

Michigan—On September 16, 2015, Michigan legislators introduced Senate Bill No. 495, which would require coverage for asynchronous store-and-forward and real-time telemedicine provision of care as long as the provider is licensed in the state where the patient is located. Additionally, the legislation would clarify that insurance policies may "not require face-to-face-contact" for telemedicine services to qualify for reimbursement.

Texas—Effective September 1, 2015, an amendment to Texas Medicaid Rule § 355.7001 clarifies that physicians will be reimbursed for telemedicine services provided in a school-based setting even if the physician is not the patient's primary care provider. To qualify, the child must be located at school and enrolled in Medicaid. A health professional, such as a school nurse, must be present with the child during treatment, and the parent or guardian must give consent before the telemedicine services are provided.

Washington—The Washington Apple Health (Medicaid) program recently held a public hearing regarding a proposed rule that would cover "HIPAA-compliant, interactive, real-time audio and video telecommunications (including web-based applications) or store and forward technology [used] to deliver covered services that are within his or her scope of practice to a client at a site other than the site where the provider is located." Eligible originating sites would include clinics, hospitals, and patients' homes, among other listed locations. As the proposed rule goes though the rulemaking process, the program has temporarily implemented a less expansive rule that covers only real-time audio and video telemedicine.

Global Happenings

EU Digital Single Market—On September 23, 2015, the European Commission launched a public consultation on Standards for the Digital Single Market ("DSM"). Andrus Ansip, Commission Vice President for the Digital Single Market, explained that common standards and interoperability will "make the best of fast-growing sectors such as cloud computing and the Internet of Things." The Commission is gathering views on priorities for standards in key technology areas that are, in the Commission's opinion, critical to achieving the DSM and, once delivered, can constitute a technological foundation upon which other standards can be built. eHealth is one of the key topics on which the Commission is looking for input. Public comments are due December 16, 2015. Please contact Cristiana Spontoni if you are interested in discussing how we can assist you with submitting comments.

EU–US Data Protection—Telehealth providers hoping to bridge the North Atlantic face challenging issues for cross-jurisdictional compliance in the area of data protection. As a general principle, EU Directive 95/46/EC and national implementing legislation prohibit the processing of personal data related to health, except in certain conditions, such as obtaining the explicit consent of the data subject or where processing is required for the purposes of preventative medicine or medical care and is performed by health care professionals subject to confidentiality obligations. In the United States, the real issue concerning data protection is often which authorities apply: U.S. Department of Health and Human Services or Federal Trade Commission regulations, state-specific data privacy rules, or all of the above. This topic is explored in an August 2015 article in eHealth Law & Policy, coauthored by Jones Day partners Alexis Gilroy, Cristiana Spontoni, and Undine von Diemar and associate Katherine Llewellyn.

Upcoming Events

October 21, 2015: Maureen Bennett will give a presentation on International Clinical Research Issues to the Boston Bar Association's Health Law Education Committee.

October 26–27, 2015: Alexis Gilroy will speak about Lessons on Telemedicine—Opportunities and Unique Diligence and Payment Considerations at the AHLA Health Plan Counsel Institute in Chicago, IL.

November 19–20, 2015: Cathy Livingston will present on Compensation Issues and Joint Ventures, Subsidiaries, and Contractual Issues at the Western Conference on Tax Exempt Organizations in Los Angeles, CA.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Kevin D. Lyles
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions